{
  "ticker": "LLY",
  "target_date": "2025-01-01",
  "actual_date": "2024-12-31",
  "collected_at": "2025-12-08T11:13:20.539175",
  "price": {
    "open": 765.29,
    "high": 768.18,
    "low": 758.64,
    "close": 766.284423828125,
    "volume": 2327000,
    "change_1d_pct": -0.24,
    "change_7d_pct": 1.91,
    "change_30d_pct": 3.46
  },
  "technicals": {
    "rsi_14": 38.37,
    "sma_20": 785.58,
    "sma_50": 799.01,
    "macd": -7.026,
    "macd_signal": -7.56,
    "macd_histogram": 0.534,
    "bb_upper": 826.92,
    "bb_lower": 744.25,
    "price_vs_sma20_pct": -2.46,
    "price_vs_sma50_pct": -4.1,
    "volume_ratio": 0.72
  },
  "fundamentals": {
    "market_cap": 891620360192,
    "pe_ratio": 48.73126,
    "forward_pe": 43.89254,
    "price_to_book": 37.44748,
    "price_to_sales": 15.005442,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.56,
    "pct_from_52w_low": 59.45
  },
  "macro": {
    "spy": {
      "price": 580.99,
      "change_1d_pct": -0.36,
      "change_7d_pct": -0.86
    },
    "vix": {
      "level": 17.35,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.57
    },
    "dollar_index": {
      "level": 108.49
    },
    "gold": {
      "price": 2629.2
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Jim Cramer\u2019s Take on Eli Lilly and Company (LLY): Bold Predictions for the Future",
      "source": "Yahoo",
      "datetime": 1735754153,
      "summary": "We recently compiled a list of the Jim Cramer\u2019s Bold Predictions About These 10 Healthcare Stocks. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been one of ",
      "url": "https://finnhub.io/api/news?id=90699ea88d2a1989666eda449ad28f9e50a9c55657b143fee5f8207bd59f95ac"
    },
    {
      "headline": "Drug-Trial Results Could Shake Up Pharma Stocks in 2025. Watch Eli Lilly, Pfizer, and More.",
      "source": "Yahoo",
      "datetime": 1735720200,
      "summary": "For pharmaceutical stocks, there are few events as crucial as the results of clinical trials for new drugs.",
      "url": "https://finnhub.io/api/news?id=984f6cf4667c8292801aeb8ca49ba050a3881af711ca3316be8e22fcd3ce6d96"
    },
    {
      "headline": "Novo Nordisk: Be Greedy When Others Are Fearful",
      "source": "SeekingAlpha",
      "datetime": 1735701071,
      "summary": "Novo Nordisk retains a strong market position in a high-growth industry, with P/E multiples poised to expand. See why NVO stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=ec4cf43d993d992d0a95bf0f5ee033ac96f0bee59ddfcfe8164898129b750b85"
    },
    {
      "headline": "GLP-1 questions emerge for 2025",
      "source": "Yahoo",
      "datetime": 1735681738,
      "summary": "The 2025 outlook for GLP-1s isn't as bullish as it once was, but all hope is not lost.",
      "url": "https://finnhub.io/api/news?id=10d16fd7419a29a826adae343cff42b8cce630ca6029cd6b54f4057e9d8f8745"
    },
    {
      "headline": "Novo Nordisk A/S (NVO): A Bull Case Theory",
      "source": "Yahoo",
      "datetime": 1735664520,
      "summary": "We came across a bullish thesis on Novo Nordisk A/S (NYSE:NVO) on Kontra Investments\u2019 Substack by Kontra. In this article, we will summarize the bulls\u2019 thesis on NVO. Novo Nordisk A/S (NYSE:NVO)\u2019s share was trading at $85.73 as of Dec 30th. NVO\u2019s trailing and forward P/E were 28.92 and 21.98 respect",
      "url": "https://finnhub.io/api/news?id=e96fa6f191b6b55ba39ac253c65b25e372610af0f58d41db52024e908bde36ea"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470584.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000291/xslF345X05/wk-form4_1734470584.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470498.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000289/xslF345X05/wk-form4_1734470498.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470366.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000287/xslF345X05/wk-form4_1734470366.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470270.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000285/xslF345X05/wk-form4_1734470270.xml"
    },
    {
      "form": "4",
      "date": "2024-12-17",
      "description": "xslF345X05/wk-form4_1734470180.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000283/xslF345X05/wk-form4_1734470180.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}